Collegium Pharmaceutical, Inc.
DE ˙ DB ˙ US19459J1043
26,00 € ↓ -0,80 (-2,99%)
2026-06-03
AKTIENPREIS
SecurityDE:354 / Collegium Pharmaceutical, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership103,609 shares
Latest Disclosed Value $ 4,797,096
Barclays Plc ownership in 354 / Collegium Pharmaceutical, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 103,609 shares of Collegium Pharmaceutical, Inc. (DE:354) valued at $4,330,856 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 74,031 shares of Collegium Pharmaceutical, Inc.. This represents a change in shares of 39.95% during the quarter. The current value of the position is $2,693,834 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (354) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:354 / Collegium Pharmaceutical, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 103,609 29,578 39.95 4,797 85.21 0.0012
2026-03-31 2025-09-30 13F/A-3 COLLEGIUM PHARMACEUTICAL COM 19459J104 74,031 -15,403 -17.22 2,590 -2.04 0.0006
2026-03-19 2025-09-30 13F/A-2 COLLEGIUM PHARMACEUTICAL COM 19459J104 75,052 -14,382 2,900 0.0008
2025-11-12 2025-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 74,031 -15,403 2,590 0.0006
2026-02-27 2025-06-30 13F/A-2 COLLEGIUM PHARMACEUTICAL COM 19459J104 89,434 15,731 21.34 2,645 20.18 0.0006
2025-08-14 2025-06-30 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 89,434 15,731 3 0.0006
2025-08-13 2025-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 89,434 15,731 3 0.0002
2026-03-17 2025-03-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 73,703 -6,051 -7.59 2,200 -3.68 0.0006
2025-05-15 2025-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 73,703 -6,051 2 0.0006
2026-03-19 2024-12-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 79,754 4,702 6.26 2,285 -21.24 0.0006
2025-02-13 2024-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 79,754 4,702 2 0.0006
2026-03-31 2024-09-30 13F/A-2 COLLEGIUM PHARMACEUTICAL COM 19459J104 75,052 45,291 152.18 2,900 202.71 0.0008
2024-11-19 2024-09-30 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 75,052 45,291 3 0.0008
2024-11-15 2024-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 75,052 45,291 3 0.0008
2026-03-23 2024-06-30 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 29,761 -17,403 -36.90 958 -47.65 0.0003
2024-08-14 2024-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 29,761 -17,403 1 0.0003
2026-03-24 2024-03-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 47,164 -25,568 -35.15 1,831 -18.23 0.0006
2024-05-15 2024-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 47,164 -25,568 2 0.0006
2026-03-25 2023-12-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 72,732 33,139 83.70 2,239 153.17 0.0008
2024-02-15 2023-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 72,732 33,139 2 0.0008
2026-03-26 2023-09-30 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 39,593 5,713 16.86 885 21.43 0.0006
2023-11-07 2023-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 39,593 5,713 1 0.0006
2026-03-30 2023-06-30 13F/A-2 COLLEGIUM PHARMACEUTICAL COM 19459J104 33,880 -769 -2.22 728 -12.39 0.0005
2023-09-20 2023-06-30 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 33,880 -769 1 0.0005
2023-08-03 2023-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 33,880 -769 1 0.0005
2026-03-30 2023-03-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 34,649 4,427 14.65 831 18.54 0.0004
2023-05-04 2023-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 34,649 4,427 1 0.0004
2026-03-30 2022-12-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 30,222 3,886 14.76 701 65.72 0.0003
2023-02-13 2022-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 30,222 3,886 1 0.0003
2022-11-03 2022-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 26,336 -15,007 -36.30 423 -42.21 0.0005
2022-08-12 2022-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 41,343 -7,683 -15.67 732 -26.65 0.0004
2022-05-16 2022-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 49,026 -23,565 -32.46 998 -26.40 0.0008
2022-02-23 2021-12-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 72,591 -11,569 -13.75 1,356 -18.41 0.0005
2022-02-14 2021-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 72,591 -11,569 1,356 0.0002
2021-11-09 2021-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 84,160 33,747 66.94 1,662 39.55 0.0007
2021-08-13 2021-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 50,413 -23,229 -31.54 1,191 -31.75 0.0006
2021-05-13 2021-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 73,642 62,394 554.71 1,745 675.56 0.0009
2021-02-11 2020-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 11,248 -4,547 -28.79 225 -31.40 0.0001
2020-11-12 2020-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 15,795 -3,137 -16.57 328 -0.91 0.0002
2020-08-12 2020-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 18,932 8,055 74.06 331 85.96 0.0003
2020-05-13 2020-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 10,877 -21,284 -66.18 178 -73.11 0.0001
2020-02-10 2019-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 32,161 7,753 31.76 662 136.43 0.0004
2019-11-15 2019-09-30 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 24,408 2,108 9.45 280 -4.44 0.0002
2019-11-14 2019-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 24,408 2,108 280 64.7363
2019-08-14 2019-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 22,300 -29,557 -57.00 293 -62.72 0.0002
2019-05-15 2019-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 51,857 14,150 37.53 786 21.30 0.0005
2019-02-14 2018-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 37,707 26,688 242.20 648 300.00 0.0005
2018-11-14 2018-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 11,019 4,709 74.63 162 8.00 0.0001
2018-08-14 2018-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 6,310 -4,447 -41.34 150 -45.65 0.0001
2018-05-15 2018-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 10,757 5,713 113.26 276 196.77 0.0002
2018-02-14 2017-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 5,044 4,518 858.94 93 1,450.00 0.0001
2017-11-14 2017-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 526 291 123.83 6 100.00 0.0000
2017-08-14 2017-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 235 -5,856 -96.14 3 -95.16 0.0000
2017-05-15 2017-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 6,091 -10,516 -63.32 62 -75.97 0.0001
2017-02-14 2016-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 16,607 5,299 46.86 258 18.35 0.0003
2016-11-14 2016-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 11,308 10,994 3,501.27 218 5,350.00 0.0002
2016-08-12 2016-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 314 200 175.44 4 100.00 0.0000
2016-05-16 2016-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 114 -210 -64.81 2 -77.78 0.0000
2016-02-12 2015-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 324 289 825.71 9 800.00 0.0000
2015-11-13 2015-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 35 -93 -72.66 1 -50.00 0.0000
2015-08-14 2015-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 128 128 2 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-05-15 2019-03-31 13F COLLEGIUM PHARMACEUTICAL OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F COLLEGIUM PHARMACEUTICAL OPT Call 9,000 -93.50 155 -92.40 n/a n/a n/a
2018-11-14 2018-09-30 13F COLLEGIUM PHARMACEUTICAL OPT Call 138,400 2,040 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-05-15 2017-03-31 13F COLLEGIUM PHARMACEUTICAL OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F COLLEGIUM PHARMACEUTICAL OPT Put 45,000 0.00 701 -19.15 n/a n/a n/a
2016-11-14 2016-09-30 13F COLLEGIUM PHARMACEUTICAL OPT Put 45,000 867 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.